Broad-spectrum antiparasitic + antiviral — interferes with pyruvate:ferredoxin oxidoreductase (PFOR) electron transfer in anaerobic protozoa. Approved for cryptosporidiosis + giardiasis; off-label for rotavirus and other viruses with mixed evidence.
Half-Life & Elimination Curve (PO: 1.5h)
Plasma (PO)t½ Decay (1.5h)
0×t½0h100%(1.48 mg/L)
1×t½1.5h50%(0.742 mg/L)
2×t½3h25%(0.371 mg/L)
3×t½4.5h12.5%(0.186 mg/L)
4×t½6h6.3%(92.8 µg/L)
5×t½7.5h3.1%(46.4 µg/L)
Elimination t½1.5h (PO)
Rate Constant (ke)0.462 h⁻¹
Time to Peak (Tmax)1.52h
Est. Peak (Cmax)1.48 mg/L
Clearance (CL)23.1 L/h
97% Washout (5×t½)7.5h
Dosing Guidelines
Oral (PO): Typical 500 mg (Range: 200–500 mg)
Pharmacokinetic Parameters
Oral (PO): Bioavailability (F): 30% · Volume of Distribution (Vd): 50 L · Absorption (ka): 0.9 h⁻¹ (t½ka ≈ 46m) [PMID 22533565]